Insights
From stratospheric antennas to implantable bio-sensors, from the thermodynamics of carbon capture to quantum technology and AI-designed biology, we use deep tech to challenge and change the status quo.
Read our latest research and insights to help you see beyond the innovation hype and find out how emerging technologies are solving important business problems.
Should robots control accuracy and precision in surgery?
Should we be designing systems that autonomously control both accuracy and precision for the best outcome of the patient? Andy Savarese explores the questions and looks ahead as the role of surgical robotics evolves ...
Six insights into successful medical device design
Designing a medical device is a challenging creative task. Not only must it be safe, reliable, easy to use and have market appeal, the product design must be accepted into people’s lifestyles ...
Getting the right distributed data architecture for you
To decentralise, or not to decentralise, that is the question. This Web3 dilemma reflects the likely thoughts of current digital leaders who want to make the best use of their digital assets while maintaining trust in their data systems ...
Can cell therapy become cheaper and easier?
Cell and gene therapy is hailed as the future of 21st century medicine but is currently too expensive to be widely used. As a principal scientist in synthetic biology, Matthew Jones is part of a team addressing this issue in ...
Real-time contamination detection for cell therapy manufacture
This whitepaper goes behind the scenes of a significant breakthrough for contamination detection in cell therapy monitoring. It tells the story of PureSentry, a prototype device for on-line, real-time detection ...
Neuropathy screening from diabetic retinopathy images
People with diabetes have an increased risk of developing serious health problems, including neuropathy. We’ve developed an AI-based system, in partnership with eminent specialists, to assess the presence of neuropathy from retinal images ...
Pathology: time for digital transformation?
In essence, the approach to pathology has remained unchanged for years – but is it time for pathologists to experience digital transformation powered by AI? ...
Overcoming regulatory hurdles for ophthalmic combination products
Regulatory approval for ophthalmic combination products is like gold dust. This instalment in our ophthalmology series walks you through the challenges and helps plot a route to market ...
